➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Colorcon
Medtronic
Johnson and Johnson
Mallinckrodt

Last Updated: July 16, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Treosulfan

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Treosulfan?

Treosulfan is an investigational drug.

There have been 37 clinical trials for Treosulfan. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2007.

The most common disease conditions in clinical trials are Leukemia, Myelodysplastic Syndromes, and Preleukemia. The leading clinical trial sponsors are medac GmbH, National Cancer Institute (NCI), and Fred Hutchinson Cancer Research Center.

Recent Clinical Trials for Treosulfan
TitleSponsorPhase
Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage SyndromeFederal Research Institute of Pediatric Hematology, Oncology and ImmunologyPhase 2
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesNational Cancer Institute (NCI)Phase 2
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesFred Hutchinson Cancer Research CenterPhase 2

See all Treosulfan clinical trials

Clinical Trial Summary for Treosulfan

Top disease conditions for Treosulfan
Top clinical trial sponsors for Treosulfan

See all Treosulfan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
McKinsey
Dow
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.